BSc Cancer Biology and Immunology with Study in Industry
About this course
BSc in Cancer Biology and Immunology with Study in Industry, a cellular molecular degree focusing on biological mechanisms. The course includes a third-year placement in a commercial or government research setting, such as a pharmaceutical company or a research institute in the UK or abroad.
Written by AI from the university's course page and module list. It can get details wrong, so check the official course page before you rely on it.
Entry requirements
A level: AAB including Chemistry and another core science/mathematics subject. Core science/mathematics subjects include: Biology, Further Mathematics, Human Biology, Mathematics and Physics. IB: 34 points overall with 17 at Higher Level, including 6, 5 (in any order) at Higher Level in Chemistry and another core science/mathematics subject. Core science/mathematics subjects include: Biology, Further Mathematics, Human Biology, Mathematics and Physics. BTEC: DDD in Applied Science BTEC National Level 3 Extended Diploma, with Distinctions in five required Chemistry units Find out more about BTEC entry requirements
See the highest paying Nursing, Pharmacy & Allied Health degrees in the UK →
What students say
Based on about 31 final-year students who answered, across similar courses at this university
- Teaching on my course: 92%
- Learning opportunities: 89%
- Assessment and feedback: 73%
- Academic support: 94%
- Organisation and management: 92%
- Learning resources: 94%
- Student voice: 83%
Do students stay on the course?
Based on about 15 students who started (a small group: a rough guide only)
- Continued on course: 60%
- Gained a higher qualification: 35%
- Left higher education: 5%
What graduates do next
Based on about 20 graduates who answered, across similar courses at this university (a small group: a rough guide only)
- Working: 55%
- Working and studying: 15%
- Further study: 30%
Most common jobs
- Administrative occupations: 20%
- Natural and social science professionals: 20%
- Elementary occupations: 15%
- Sales occupations: 10%
- Caring personal services: 10%
- Find their work meaningful: 95%
- Feel on track for their future plans: 50%
- Use what they learnt on the course: 45%
Where graduates work (5 years on)
Based on about 115 graduates, across similar courses at this university
- North East: 1%
- North West: 5%
- Yorkshire and the Humber: 3%
- East Midlands: 4%
- West Midlands: 9%
- East of England: 5%
- London: 25%
- South East: 19%
- South West: 26%
- Wales: 1%
- Scotland: 1%
Who gets in
Based on about 10 students who started (a small group: a rough guide only)
- A levels: 65%
- Baccalaureate: 10%
- Other HE qualification: 25%
Accreditation & quality ratings
TEF 2023 (whole university): Silver overall, Silver for student experience, Gold for student outcomes.
Questions about this course
How much do graduates of BSc Cancer Biology and Immunology with Study in Industry at University of Bristol earn?
The median salary is £26,500 after 15 months, £29,000 after 3 years, £42,000 after 5 years. After five years the middle half of graduates earn between £33,000 and £51,000. The £42,000 median after five years is £4,000 more than the UK median for Anatomy, physiology and pathology.
What do graduates of BSc Cancer Biology and Immunology with Study in Industry at University of Bristol do next?
95% were in work or further study 15 months after finishing (Graduate Outcomes 2023-24).
Are students happy with the teaching on BSc Cancer Biology and Immunology with Study in Industry at University of Bristol?
92% of final-year students were positive about the teaching in the National Student Survey 2025-26.
What grades do I need for BSc Cancer Biology and Immunology with Study in Industry at University of Bristol?
The typical offer is AAB at A level, or 34 points in the IB. The average entrant had 154 UCAS points.
How many students continue on BSc Cancer Biology and Immunology with Study in Industry at University of Bristol?
60% of students continued into their second year, and 5% left higher education.